Journal of Psychopharmacology

SJR Rank #1,983H-index: 150SJR: 1.683Best quartile: Q1APC: US$4,400
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • Medicine (miscellaneous)Q1
  • PharmacologyQ1
  • Pharmacology (medical)Q1
  • Psychiatry and Mental HealthQ1

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatmentTreatment of Major DepressionPsychedelics and Drug StudiesNeuroscience and Neuropharmacology ResearchForensic Toxicology and Drug AnalysisCannabis and Cannabinoid ResearchMemory and Neural MechanismsBipolar Disorder and TreatmentAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs095190285380

Documents per Year

20222025050100150200

Detailed Information

ISSN

1461-7285, 0269-8811

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

5.67

References per Document

65.37

Coverage

1987-2026

Scope

The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.

Metrics from SCImago Journal Rank 2025. View on SCImago